Search filters

List of works by Peter Brønnum Nielsen

'Real-world' observational studies in arrhythmia research: data sources, methodology, and interpretation. A position document from European Heart Rhythm Association (EHRA), endorsed by Heart Rhythm Society (HRS), Asia-Pacific HRS (APHRS), and Latin

scientific article published on 14 November 2019

A two-sided evaluation of benefit and harm from antithrombotic treatment in atrial fibrillation: Balancing clinical application and statistical methodology

scientific article published on 21 July 2016

Adding Rigor to Stroke Rate Investigations in Patients With Atrial Fibrillation

scientific article published on 01 January 2017

Albuminuria and Risk of Cardiovascular Events and Mortality in a General Population of Patients with Type 2 Diabetes without Cardiovascular Disease: A Danish Cohort Study

scientific article published on 20 March 2020

All Types of Hemorrhagic Stroke Are Not Created Equally-Reply

scientific article published in September 2017

Anticoagulant treatment of cancer-associated venous thromboembolism: Interpreting real-world data with caution

scientific article published on 07 August 2018

Associations between socioeconomic status, atrial fibrillation and outcomes: A systematic review

article

Atrial fibrillation patients categorized as "not for anticoagulation" according to the 2014 Canadian Cardiovascular Society algorithm are not "low risk".

scientific article published on 17 October 2014

Atrial flutter and thromboembolic risk: a systematic review

scientific article published on 06 July 2015

Cancer-associated venous thromboembolism and the non-vitamin K antagonist oral anticoagulants: a review of clinical outcomes and patient perspectives

scientific article published on 10 September 2020

Causal Inference From Real-World Data: A Request for Asking the Proper Research Question

scientific article published on 01 July 2018

Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study

scientific article published on 16 June 2016

Comparison of Atrial Fibrillation Guidelines.

scientific article

Composite end point analyses of non-vitamin K antagonist oral anticoagulants compared with warfarin in patients with atrial fibrillation

scientific article published on October 2015

Correspondence: Current opinion of the ESC Working Group on Cardiovascular Pharmacotherapy and ESC Council on Stroke

scientific article published on 26 August 2019

Data mining to assess variations in oral anticoagulant treatment.

scientific article

Effectiveness and Safety of Standard-Dose Nonvitamin K Antagonist Oral Anticoagulants and Warfarin Among Patients With Atrial Fibrillation With a Single Stroke Risk Factor: A Nationwide Cohort Study.

scientific article published on 14 June 2017

Effectiveness and safety of edoxaban in patients with atrial fibrillation: data from the Danish nationwide cohort

scientific article published on 27 November 2019

Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study

scientific article

Effectiveness and safety of rivaroxaban and warfarin in patients with unprovoked venous thromboembolism: a propensity-matched nationwide cohort study.

scientific article

Effectiveness and safety of self-managed oral anticoagulant therapy compared with direct oral anticoagulants in patients with atrial fibrillation

scientific article published in Scientific Reports

Effectiveness of self-managed oral anticoagulant therapy in patients with recurrent venous thromboembolism. A propensity-matched cohort study.

scientific article published on 2 June 2016

Etiological Research Using Observational Data, and Net Clinical Benefit. Simplicity and Practicality Matter

scientific article published on 06 March 2019

Evaluation of the C2HEST Risk Score as a Possible Opportunistic Screening Tool for Incident Atrial Fibrillation in a Healthy Population (From a Nationwide Danish Cohort Study)

scientific article published on 10 October 2019

Extended oral anticoagulation after incident venous thromboembolism - a paradigm shift?

scientific article published on 10 April 2020

Female Sex Is a Risk Modifier Rather Than a Risk Factor for Stroke in Atrial Fibrillation: Should We Use a CHA2DS2-VA Score Rather Than CHA2DS2-VASc?

scientific article published in February 2018

Glycemic Status and Thromboembolic Risk in Patients With Atrial Fibrillation and Type 2 Diabetes Mellitus

scientific article published on 01 May 2019

Improvement of anticoagulant treatment using a dynamic decision support algorithm: a Danish Cohort study.

scientific article

Incidence and prognostic factors for recurrence of intracerebral hemorrhage in patients with and without atrial fibrillation: A cohort study

scientific article published on 21 April 2020

Intracranial hemorrhage and subsequent ischemic stroke in patients with atrial fibrillation: a nationwide cohort study

scientific article published on 01 June 2015

Left atrial size and risk of stroke in patients in sinus rhythm. A systematic review.

scientific article

Letter by Nielsen and Johnsen Regarding Article, "Optimal Timing of Anticoagulant Treatment After Intracerebral Hemorrhage in Patients With Atrial Fibrillation"

scientific article published on 10 March 2017

Letter by Nielsen et al Regarding Article, "Ischemic Stroke Risk in Patients With Atrial Fibrillation and CHA2DS2-VASc Score of 1: Systematic Review and Meta-Analysis"

scientific article published on 09 June 2016

Misconceptions on Interpretation of Risk Prediction Tools in Atrial Fibrillation

scientific article published on 01 May 2016

Net Clinical Benefit for Oral Anticoagulation, Aspirin, or No Therapy in Nonvalvular Atrial Fibrillation Patients With 1 Additional Risk Factor of the CHA2DS2-VASc Score (Beyond Sex)

scientific article published on 01 July 2015

Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Atrial Fibrillation Patients With Intracerebral Hemorrhage

scientific article published on 01 April 2019

Non-valvular atrial fibrillation patients with none or one additional risk factor of the CHA2DS2-VASc score. A comprehensive net clinical benefit analysis for warfarin, aspirin, or no therapy

scientific article published on 30 July 2015

Non-vitamin K antagonist oral anticoagulants and the treatment of venous thromboembolism in cancer patients: a semi systematic review and meta-analysis of safety and efficacy outcomes

scientific article

Nonvitamin K Antagonist Oral Anticoagulants Versus Warfarin in Atrial Fibrillation Patients and Risk of Dementia: A Nationwide Propensity-Weighted Cohort Study.

scientific article published on 29 May 2019

Outcomes Associated With Resuming Warfarin Treatment After Hemorrhagic Stroke or Traumatic Intracranial Hemorrhage in Patients With Atrial Fibrillation

scientific article published on 20 February 2017

Pharmacoepidemiological comparisons between acenocoumarol and dabigatran: interpretation of data reflecting clinical practice

scientific article published on 03 February 2016

Predictors of Not Initiating Anticoagulation After Incident Venous Thromboembolism: A Danish Nationwide Cohort Study

scientific article published on 10 October 2019

Recalibration of the HAS-BLED Score: Should Hemorrhagic Stroke Account for One or Two Points?

scientific article published on 10 September 2015

Recent Diabetes and Atrial Fibrillation Report Diverges From Pre-Existing Evidence

article

Renal function and non-vitamin K oral anticoagulants in comparison with warfarin on safety and efficacy outcomes in atrial fibrillation patients: a systemic review and meta-regression analysis

scientific article

Response

Response by Overvad et al to Letter Regarding Article, "Female Sex Is a Risk Modifier Rather Than a Risk Factor for Stroke in Atrial Fibrillation: Should We Use a CHA2DS2-VA Score Rather Than CHA2DS2-VASc?"

scientific article published on 01 July 2018

Restarting Anticoagulant Treatment After Intracranial Hemorrhage in Patients With Atrial Fibrillation and the Impact on Recurrent Stroke, Mortality, and Bleeding: A Nationwide Cohort Study

scientific article published on 9 June 2015

Restarting oral anticoagulant therapy after major bleeding in atrial fibrillation: A systematic review and meta-analysis

scientific article published on 14 March 2018

Risk Stratification for Ischemic Cerebrovascular Events and Mortality among Intracerebral Hemorrhage Patients with and without Atrial Fibrillation: A Nationwide Cohort Study

scientific article published on 17 December 2019

Risk of Recurrent Venous Thromboembolism: A Danish Nationwide Cohort Study

scientific article published on 01 September 2018

Risk of recurrence and bleeding in patients with cancer-associated venous thromboembolism treated with rivaroxaban: A nationwide cohort study

scientific article published on 14 February 2019

Rivaroxaban Versus Warfarin and Risk of Post-Thrombotic Syndrome Among Patients with Venous Thromboembolism.

scientific article published on 21 February 2018

Searching for High-Risk Venous Thromboembolism Patients Using Risk Scores: Adding to the Heap or Closing a Gap?

scientific article published on 01 October 2018

Self-Management of Anticoagulant Therapy in Mechanical Heart Valve Patients: A Matched Cohort Study.

scientific article published on 3 November 2015

Self-managed oral anticoagulant therapy: a call for implementation

scientific article published on 03 February 2016

Sex differences in risk of incident venous thromboembolism in heart failure patients

scientific article published on 21 August 2018

Sex differences in treatment quality of self-managed oral anticoagulant therapy: 6,900 patient-years of follow-up

scientific article

Should Patients With Atrial Fibrillation and 1 Stroke Risk Factor (CHA2DS2-VASc Score 1 in Men, 2 in Women) Be Anticoagulated? Yes: Even 1 Stroke Risk Factor Confers a Real Risk of Stroke

scientific article published on 01 April 2016

Stroke Risk Stratification: CHA2DS2-VA or CHA2DS2-VASc?

scientific article published on 10 September 2018

Stroke and bleeding risk scores in patients with atrial fibrillation and valvular heart disease: evaluating 'valvular heart disease' in a nationwide cohort study

scientific article published on 01 January 2019

Stroke and mortality after atrial fibrillation-a global struggle

scientific article published on 08 August 2016

Stroke and thromboembolic event rates in atrial fibrillation according to different guideline treatment thresholds: A nationwide cohort study

scientific article (publication date: 6 June 2016)

Stroke risk in female patients with atrial fibrillation: Relationship to current guideline recommendations

scientific article published on 12 July 2018

The HAS-BLED, ATRIA and ORBIT Bleeding Scores in Atrial Fibrillation Patients Using Non-Vitamin K Antagonist Oral Anticoagulants.

scientific article published on 21 December 2017

The risks of risk scores for stroke risk assessment in atrial fibrillation

scientific article published on 11 March 2015

The value of the European society of cardiology guidelines for refining stroke risk stratification in patients with atrial fibrillation categorized as low risk using the anticoagulation and risk factors in atrial fibrillation stroke score: a nationw

scientific article published on 01 November 2014

Thromboembolic and bleeding outcomes in patients with atrial fibrillation and valvular heart disease: A descriptive nationwide cohort study

scientific article published on 23 June 2020

Thromboembolism and bleeding complications in anticoagulated patients with atrial fibrillation and native aortic or mitral valvular heart disease: A descriptive nationwide cohort study

scientific article published on 31 January 2020

Treatment thresholds for stroke prevention in atrial fibrillation: observations on the CHA2DS2-VASc score

scientific article published on 12 August 2016

Type 1 versus type 2 diabetes and thromboembolic risk in patients with atrial fibrillation: A Danish nationwide cohort study

scientific article published on 01 October 2018

Understanding the Value of Real-World Evidence: Focus on Stroke Prevention in Atrial Fibrillation with Rivaroxaban

scientific article published on 22 March 2018

Using the CHA2DS2-VASc Score for Stroke Prevention in Atrial Fibrillation: A Focus on Vascular Disease, Women, and Simple Practical Application

scientific article

[In Process Citation]

β-Blockers in Atrial Fibrillation Patients With or Without Heart Failure: Association With Mortality in a Nationwide Cohort Study

scientific article published on February 2016

Paulina is supported by:

About Paulina

Help